Novel PCSK9 inhibitor lowers LDL-c in another large phase 3 study
Evan Stein, MD, PhD
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Encouraging data with APOC3 siRNA in mixed hyperlipidemia
Christie Ballantyne, MD
ANGPTL3 RNAi therapeutic lowers atherogenic lipids and lipoproteins in patients with mixed hyperlipidemia
Robert S. Rosenson, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.